You are seeing this message because your Web browser does not support basic Web standards. Find out more about why this message is appearing and what you can do to make your experience on this site better.


ABOUT JAMA
Advanced Search

Welcome   | My Account | E-mail Alerts | Access Rights | Sign In


  Vol. 297 No. 2, January 10, 2007 TABLE OF CONTENTS
  JAMA
  •  Online Features
  Letters
 This Article
 •Full text
 •PDF
 •Send to a friend
 • Save in My Folder
 •Save to citation manager
 •Permissions
 Citing Articles
 •Contact me when this article is cited
 Related Content
 •Related letters
 •Related article
 •Similar articles in JAMA
 Topic Collections
 •Otolaryngology/ Head & Neck Surgery
 •Middle/ External Ear Disorders
 •Pediatrics
 •Pediatrics, Other
 •Drug Therapy, Other
 •Alert me on articles by topic
 Social Bookmarking
  Add to CiteULike Add to Connotea Add to Del.icio.us Add to Digg Add to Reddit Add to Technorati
What's this?

Wait-and-See Prescription for Acute Otitis Media

Since this article does not have an abstract, we have provided the first 150 words of the full text and any section headings.

To the Editor: Dr Spiro and colleagues1 reported the results of a trial of "wait-and-see prescription" (WASP) for treatment of acute otitis media. In an accompanying editorial, Dr Little2 stated that it would be unwise to use the WASP approach to antimicrobial therapy if a child with acute otitis media has already had high fever and severe otalgia for more than 72 hours.

However, Spiro et al did not use these as exclusionary criteria; in their study, patients were excluded only if they appeared "toxic," not based on height of fever or pretherapy symptom duration and severity. Little's implicit assumption that the subgroup identified by his criteria would fare poorly with expectant management, which may be correct, could be substantiated from Spiro et al if such patients were studied and they either (1) always had the prescription filled when randomized to the WASP group or (2) had significantly worse outcomes . . . [Full Text of this Article]

James R. Johnson, MD
johns007@umn.edu
VA Medical Center
Minneapolis, Minn



Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati     What's this?

RELATED LETTERS

Wait-and-See Prescription for Acute Otitis Media—Reply
Paul Little
JAMA. 2007;297(2):152.
EXTRACT | FULL TEXT  

Wait-and-See Prescription for Acute Otitis Media—Reply
David M. Spiro and Eugene D. Shapiro
JAMA. 2007;297(2):152-153.
EXTRACT | FULL TEXT  

RELATED ARTICLE

Wait-and-See Prescription for the Treatment of Acute Otitis Media: A Randomized Controlled Trial
David M. Spiro, Khoon-Yen Tay, Donald H. Arnold, James D. Dziura, Mark D. Baker, and Eugene D. Shapiro
JAMA. 2006;296(10):1235-1241.
ABSTRACT | FULL TEXT  






HOME | CURRENT ISSUE | PAST ISSUES | TOPIC COLLECTIONS | CME | SUBMIT | SUBSCRIBE | HELP
CONDITIONS OF USE | PRIVACY POLICY | CONTACT US | SITE MAP
 
© 2007 American Medical Association. All Rights Reserved.